Estrogen and cancers of the colorectum, breast, and lung in postmenopausal women
暂无分享,去创建一个
[1] H. Kawai. Estrogen receptors as the novel therapeutic biomarker in non-small cell lung cancer. , 2014, World journal of clinical oncology.
[2] H. Brenner,et al. Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: results from a German population-based case-control study , 2014, BMC Cancer.
[3] T. Burns,et al. Targeting the estrogen pathway for the treatment and prevention of lung cancer. , 2014, Lung cancer management.
[4] M. Muramatsu,et al. [Association between colorectal cancer and estrogens]. , 2014, Nihon rinsho. Japanese journal of clinical medicine.
[5] L. Marks,et al. Lung , 2013, ALERT • Adverse Late Effects of Cancer Treatment.
[6] Intratumoral localization and activity of 17β-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer: a potent prognostic factor , 2013, Journal of Translational Medicine.
[7] H. Brenner,et al. Colorectal cancer risk associated with hormone use varies by expression of estrogen receptor-β. , 2013, Cancer Research.
[8] Y. Kakeji,et al. Estrogen receptor‐β gene polymorphism and colorectal cancer risk: Effect modified by body mass index and isoflavone intake , 2013, International journal of cancer.
[9] N. Shah,et al. Intracystic papillary carcinoma of breast: report of three cases and review of the literature , 2012, BMJ Case Reports.
[10] R. Prentice,et al. Estrogen plus progestin and colorectal cancer incidence and mortality. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] H. Sasano,et al. Co-expression of estrogen receptor beta and aromatase in Japanese lung cancer patients: gender-dependent clinical outcome. , 2012, Life sciences.
[12] M. Teh,et al. Female reproductive factors, gene polymorphisms in the estrogen metabolism pathway, and risk of lung cancer in Chinese women. , 2012, American journal of epidemiology.
[13] S. Horvath,et al. Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer. , 2011, Lung cancer.
[14] J. Cerhan,et al. Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women , 2011, Gut.
[15] N. Harada,et al. Sex steroid hormones in pairs of tumor and serum from breast cancer patients and pathobiological role of androstene‐3β, 17β‐diol , 2011, Cancer science.
[16] Mamoun Younes,et al. Oestrogen receptor‐β CA repeat polymorphism is associated with incidence of colorectal cancer among females , 2011, Histopathology.
[17] G. Vlastos,et al. Lung cancer mortality risk among breast cancer patients treated with anti‐estrogens , 2011, Cancer.
[18] M. Inoue,et al. Plasma Isoflavones and the Risk of Lung Cancer in Women: A Nested Case–Control Study in Japan , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[19] A. Schatzkin,et al. Reproductive history and risk of colorectal cancer in postmenopausal women. , 2010, Journal of the National Cancer Institute.
[20] J. Manson,et al. Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial. , 2010, Journal of the National Cancer Institute.
[21] S. Batra,et al. Lung cancer in women: role of estrogens , 2010, Expert review of respiratory medicine.
[22] M. Sawabe,et al. Role of methylation of the hMLH1 gene promoter in the development of gastric and colorectal carcinoma in the elderly , 2010, Geriatrics & gerontology international.
[23] Takashi Suzuki,et al. In situ estrogen production and its regulation in human breast carcinoma: From endocrinology to intracrinology , 2009, Pathology international.
[24] T. Aas,et al. Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status , 2009, The Journal of Steroid Biochemistry and Molecular Biology.
[25] J. Siegfried,et al. Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer. , 2009, Lung cancer.
[26] G. Thomas,et al. Breast cancer in the elderly , 2004 .
[27] Takashi Suzuki,et al. Steroid sulfatase and estrogen sulfotransferase in colon carcinoma: regulators of intratumoral estrogen concentrations and potent prognostic factors. , 2009, Cancer research.
[28] R. Shore,et al. Postmenopausal Levels of Endogenous Sex Hormones and Risk of Colorectal Cancer , 2009, Cancer Epidemiology Biomarkers & Prevention.
[29] Takuji Iwase,et al. Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] M. Inoue,et al. Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] D. Winter,et al. Oestrogen and the colon: potential mechanisms for cancer prevention. , 2008, The Lancet. Oncology.
[32] M. Barone,et al. Estrogens, phytoestrogens and colorectal neoproliferative lesions , 2008, Genes & Nutrition.
[33] J. Manson,et al. Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. , 2007, Cancer research.
[34] E. Halm,et al. Sex differences in lung cancer survival: do tumors behave differently in elderly women? , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] P. Taylor,et al. Usefulness of Body Mass Index as a Sufficient Adiposity Measurement for Sex Hormone Concentration Associations in Postmenopausal Women , 2006, Cancer Epidemiology Biomarkers & Prevention.
[36] N. Harada,et al. Estrogen-metabolizing enzymes in breast cancers from women over the age of 80 years. , 2006, The Journal of clinical endocrinology and metabolism.
[37] A. Potti,et al. Hormone replacement therapy is associated with decreased survival in women with lung cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] R. Wolff,et al. Associations between ERα, ERβ, and AR Genotypes and Colon and Rectal Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.
[39] D. Harrison,et al. ERβ isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates , 2005, The Journal of pathology.
[40] R. Wolff,et al. Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[41] N. Harada,et al. Breast carcinoma in women over the age of 85: distinct histological pattern and androgen, oestrogen, and progesterone receptor status , 2003, Histopathology.
[42] V. Beral,et al. Evidence from randomised trials on the long-term effects of hormone replacement therapy , 2002, The Lancet.
[43] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[44] L. Melton,et al. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. , 2001, The Journal of clinical endocrinology and metabolism.
[45] J. Potter,et al. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. , 2001, Cancer research.
[46] Y. Ouchi,et al. Molecular cloning and characterization of human estrogen receptor βcx: A potential inhibitor of estrogen action in human , 1998 .
[47] Hajime Orimo,et al. Isolation and radiation hybrid mapping of dinucleotide repeat polymorphism at the human estrogen receptor β locus , 1998, Journal of Human Genetics.
[48] J. Corton,et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. , 1998, Endocrinology.
[49] Y. Ouchi,et al. Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human. , 1998, Nucleic acids research.
[50] J. Gustafsson,et al. Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[51] F. Koerner,et al. Solid papillary carcinoma of the breast. A form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma. , 1995, The American journal of surgical pathology.
[52] M. Thun,et al. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. , 1995, Journal of the National Cancer Institute.
[53] T. Iwase,et al. CLINICOPATHOLOGICAL IMAGES OF INTRACYSTIC BREAST CARCINOMA , 1994 .
[54] E. Wynder,et al. Re: Endocrine factors and adenocarcinoma of the lung in women. , 1994, Journal of the National Cancer Institute.
[55] J. Crowley,et al. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[56] R. Hoover,et al. Risk of cancer in women receiving hormone replacement therapy , 1989, International journal of cancer.
[57] A. Forrest,et al. Significance of aromatase activity in human breast cancer. , 1982, Cancer research.